Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA, Kiefer MC, Tomei LD, Umansky SR (1997) SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A 94(25):13636–13641

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chien AJ, Conrad WH, Moon RT (2009) A Wnt survival guide: from flies to human disease. J Invest Dermatol 129(7):1614–1627. https://doi.org/10.1038/jid.2008.445

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Ponten F (2015) Proteomics. Tissue-based map of the human proteome. Science 347(6220):1260419. https://doi.org/10.1126/science.1260419

Article  CAS  PubMed  Google Scholar 

Fox SA, Richards AK, Kusumah I, Perumal V, Bolitho EM, Mutsaers SE, Dharmarajan AM (2013) Expression profile and function of Wnt signaling mechanisms in malignant mesothelioma cells. Biochem Biophys Res Commun 440(1):82–87. https://doi.org/10.1016/j.bbrc.2013.09.025

Article  CAS  PubMed  Google Scholar 

Jacob F, Ukegjini K, Nixdorf S, Ford CE, Olivier J, Caduff R, Scurry JP, Guertler R, Hornung D, Mueller R, Fink DA, Hacker NF, Heinzelmann-Schwarz VA (2012) Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients. PLoS One 7(2):e31885. https://doi.org/10.1371/journal.pone.0031885

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ford CE, Jary E, Ma SS, Nixdorf S, Heinzelmann-Schwarz VA, Ward RL (2013) The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells. PLoS One 8(1):e54362. https://doi.org/10.1371/journal.pone.0054362

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kamposioras K, Konstantara A, Kotoula V, Lakis S, Kouvatseas G, Akriviadis E, Vrettou E, Dionysopoulos D, Krikelis D, Papadopoulou K, Charalambous E, Chrisafi S, Konstantaras C, Fountzilas G (2013) The prognostic significance of WNT pathway in surgically-treated colorectal cancer: beta-catenin expression predicts for disease-free survival. Anticancer Res 33(10):4573–4584

PubMed  Google Scholar 

Huang D, Yu B, Deng Y, Sheng W, Peng Z, Qin W, Du X (2010) SFRP4 was overexpressed in colorectal carcinoma. J Cancer Res Clin Oncol 136(3):395–401. https://doi.org/10.1007/s00432-009-0669-2

Article  CAS  PubMed  Google Scholar 

Abu-Jawdeh G, Comella N, Tomita Y, Brown LF, Tognazzi K, Sokol SY, Kocher O (1999) Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy. Lab Investig 79(4):439–447

CAS  PubMed  Google Scholar 

Chung MT, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Chu TY, Lai HC, Lin YW (2009) Promoter methylation of SFRPs gene family in cervical cancer. Gynecol Oncol 112(2):301–306. https://doi.org/10.1016/j.ygyno.2008.10.004

Article  CAS  PubMed  Google Scholar 

Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R (2006) Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res 12(7 Pt 1):2109–2116. https://doi.org/10.1158/1078-0432.CCR-05-2468

Article  CAS  PubMed  Google Scholar 

Bu XM, Zhao CH, Zhang N, Gao F, Lin S, Dai XW (2008) Hypermethylation and aberrant expression of secreted frizzled-related protein genes in pancreatic cancer. World J Gastroenterol 14(21):3421–3424

Article  CAS  PubMed  PubMed Central  Google Scholar 

Surana R, Sikka S, Cai W, Shin EM, Warrier SR, Tan HJ, Arfuso F, Fox SA, Dharmarajan AM, Kumar AP (2014) Secreted frizzled related proteins: implications in cancers. Biochim Biophys Acta 1845(1):53–65. https://doi.org/10.1016/j.bbcan.2013.11.004

Article  CAS  PubMed  Google Scholar 

Pohl S, Scott R, Arfuso F, Perumal V, Dharmarajan A (2015) Secreted frizzled-related protein 4 and its implications in cancer and apoptosis. Tumour Biol 36(1):143–152. https://doi.org/10.1007/s13277-014-2956-z

Article  CAS  PubMed  Google Scholar 

Horvath LG, Henshall SM, Kench JG, Saunders DN, Lee CS, Golovsky D, Brenner PC, O'Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL (2004) Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro. Clin Cancer Res 10(2):615–625

Article  CAS  PubMed  Google Scholar 

Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM (2007) Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Prostate 67(10):1081–1090. https://doi.org/10.1002/pros.20607

Article  CAS  PubMed  Google Scholar 

Mortensen MM, Hoyer S, Lynnerup AS, Orntoft TF, Sorensen KD, Borre M, Dyrskjot L (2015) Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy. Sci Rep 5:16018. https://doi.org/10.1038/srep16018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sandsmark E, Andersen MK, Bofin AM, Bertilsson H, Drablos F, Bathen TF, Rye MB, Tessem MB (2017) SFRP4 gene expression is increased in aggressive prostate cancer. Sci Rep 7(1):14276. https://doi.org/10.1038/s41598-017-14622-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, Landers T, Dolgalev I, Major JE, Wilson M, Socci ND, Lash AE, Heguy A, Eastham JA, Scher HI, Reuter VE, Scardino PT, Sander C, Sawyers CL, Gerald WL (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1):11–22. https://doi.org/10.1016/j.ccr.2010.05.026

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Xia XQ, Jia Z, Sawyers A, Yao H, Wang-Rodriquez J, Mercola D, McClelland M (2010) In silico estimates of tissue components in surgical samples based on expression profiling data. Cancer Res 70(16):6448–6455. https://doi.org/10.1158/0008-5472.CAN-10-0021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jia Z, Wang Y, Sawyers A, Yao H, Rahmatpanah F, Xia XQ, Xu Q, Pio R, Turan T, Koziol JA, Goodison S, Carpenter P, Wang-Rodriguez J, Simoneau A, Meyskens F, Sutton M, Lernhardt W, Beach T, Monforte J, McClelland M, Mercola D (2011) Diagnosis of prostate cancer using differentially expressed genes in stroma. Cancer Res 71(7):2476–2487. https://doi.org/10.1158/0008-5472.CAN-10-2585

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Xu S, McClelland M, Rahmatpanah F, Sawyers A, Jia Z, Mercola D (2012) An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account. PLoS One 7(9):e45178. https://doi.org/10.1371/journal.pone.0045178

Article  CAS  PubMed  PubMed Central  Google Scholar 

Erho N, Crisan A, Vergara IA, Mitra AP, Ghadessi M, Buerki C, Bergstralh EJ, Kollmeyer T, Fink S, Haddad Z, Zimmermann B, Sierocinski T, Ballman KV, Triche TJ, Black PC, Karnes RJ, Klee G, Davicioni E, Jenkins RB (2013) Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy. PLoS One 8(6):e66855. https://doi.org/10.1371/journal.pone.0066855

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR (2014) A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur Urol 66(3):550–560. https://doi.org/10.1016/j.eururo.2014.05.004

Article